RUPA CORNELL is Senior Director and Legal Counsel at Biogen, global developer, manufacturer and marketer of innovative therapies for patients living with serious neurological, autoimmune and rare diseases. At Biogen, Rupa is the lead counsel for the Specialty Medicines Group (SMG), encompassing Biogen’s Multiple Sclerosis product line (over $8 billion). Rupa actively advises the management team for SMG on strategy and direction for the business, as well as providing day-to-day support for a variety of functions involved in SMG. Rupa also provides legal advice on social media platforms, activities and policies for Biogen and serves as a member of its Social Media Council. Rupa has been practicing law for over 18 years. She joined Biogen in 2014 and previously worked at Boston Scientific Corporation, a worldwide medical device company, for 8 years, serving as lead counsel for the Urology/Women’s Health division (approx. $500 million). Prior to BSC, Rupa practiced international corporate law with a focus on cross-border mergers & acquisitions at Choate, Hall & Stewart and Testa, Hurwitz & Thibeault in Boston. Prior to Boston, she worked at Squire, Sanders & Dempsey in London and Morrison & Foerster in San Francisco. Rupa served as a judicial clerk to the Honorable Judge John T. Nixon in the Federal District Court of Middle Tennessee. Rupa graduated for Cornell Law School, cum laude, in 1998 and from Vanderbilt University, summa cum laude, in 1995.